Home Cart 0 Sign in  

[ CAS No. 231958-04-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 231958-04-6
Chemical Structure| 231958-04-6
Structure of 231958-04-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 231958-04-6 ]

Related Doc. of [ 231958-04-6 ]

Alternatived Products of [ 231958-04-6 ]

Product Details of [ 231958-04-6 ]

CAS No. :231958-04-6 MDL No. :MFCD01861378
Formula : C13H17NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :ITZUJURBEZPZOD-UHFFFAOYSA-N
M.W : 251.28 Pubchem ID :10634482
Synonyms :

Calculated chemistry of [ 231958-04-6 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.38
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 68.61
TPSA : 75.63 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.34
Log Po/w (XLOGP3) : 2.11
Log Po/w (WLOGP) : 2.85
Log Po/w (MLOGP) : 2.24
Log Po/w (SILICOS-IT) : 1.67
Consensus Log Po/w : 2.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.64
Solubility : 0.571 mg/ml ; 0.00227 mol/l
Class : Soluble
Log S (Ali) : -3.33
Solubility : 0.118 mg/ml ; 0.000469 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.12
Solubility : 0.193 mg/ml ; 0.000767 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.35

Safety of [ 231958-04-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H317-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 231958-04-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 231958-04-6 ]
  • Downstream synthetic route of [ 231958-04-6 ]

[ 231958-04-6 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 24424-99-5 ]
  • [ 2458-12-0 ]
  • [ 231958-04-6 ]
YieldReaction ConditionsOperation in experiment
100% With sodium hydroxide In water at 20℃; for 18 h; To a solution of 3-amino-4-methyl benzoic acid (2.0 g, 13.2 mmol) in water (25 mL) and 1N sodium hydroxide (25 mL) was added di-tert-butyl dicarbonate (4.3 g, 19.8 mmol) and the reaction was stirred for 18 hours at ambient temperature. The reaction was partitioned between ethyl acetate and 5percent aqueous citric acid. The organic layer was washed with water and brine and dried over magnesium sulfate. The material was filtered and concentrated to provide the protected aniline as a pink solid (3.3 g, quantitative yield).
91% at 50℃; A mixture of commercially-available 4-amino-3-methylbenzoic acid (100 g, 0.66 mol) and di-tertbutyl dicarbonate (150 g, 0.68 mol) in THF (1000 mL) was slowly heated to 50°C overnight. The resulting mixture was cooled to rt and the solvent was removed on a rotary evaporator. The resulting solids were triturated with hexanes and dried in vacuo to afford 151 g (91percent) of the crude BOC-protected aniline intermediate as a light pink solid. To the above, light-pink solid was added 1- (3- dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (127 g, 0.66 mol), HOBt (90 g, 0.66 mol), and DMF (1000 ml), and the resulting mixture was stirred at rt for 30 minutes followed by addition of methoxyamine hydrochloride (55 g, 0.66 mol) in one portion. After stirring for 10 min, the mixture was cooled using an ice bath. Diisopropyl-ethylamine (250 ml, 1.4 mol) was added at such a rate so as to maintain the internal reaction temperature below 25°C. After the addition was complete, the ice bath was removed and the reaction was stirred overnight at rt. The reaction mixture was partitioned between 0.5 L of water and 1.5 L of EtOAc and the resulting layers were separated. The aqueous portion was extracted with additional EtOAc (400 mL x 3), and the combined organic extracts were washed with, water (300 mL x 3), cold 0.5 N aqueous HC1 (400 mL x 2), and water (500 mL). The product was then extracted with cold 0.5 N aqueous NaOH (300 mL x 3) and the combined basic aqueous extracts were neutralized to pH = 8 by a slow addition of cold 0.5 N aqueous HC1. The resulting solid which precipitated was collected by filtration and washed with cold water.'The wet solid was decolorized in hot EtOH with active charcoal to give 106 g of white solid as the BOC-protected N-methoxyamide intermediate. To a slurry of the above solid (91 g, 0.32 mol) in 1,4-dioxane (400 mL) at rt was added a 4M solution of HC1 in dioxane (400 mL), and the resulting mixture was stirred at rt overnight. Diethyl ether (1000 mL) was added and the precipitated solid was collected by filtration and triturated with a hot EtOH/H20 mixture (4: 1 v/v). Drying the resulting solid in vacuo afforded 53 g of the pure hydrochloride salt (1D) as a white solid. 1H NMR (d6-DMSO) : 6 9.5-9. 9 (br. s, 1H), 7.75 (s, 1H), 7.55 (d, 1H), 7.36 (d, 1H), 3.70 (s, 3H), 2.38 (s, 3H).
88% at 50℃; A suspension of 3-amino-4-methylbenzoic acid (20.0 g, 132 mmol) and N-(tert-butoxycarbonyl)anhydride (30.0 g, 219 mmol) in THF (200 mL) was heated and stirred at 50 °C overnight. The resulting mixture was cooled to rt. The solvent was evaporated in vacuo, and the crude product was recrystallized from EtOAc to afford 7 (29.1 g, 88 percent) as a pink solid. 1H NMR (DMSO-d6): δ 12.8 (s, 1H), 8.66 (s, 1H), 7.97 (s, 1H), 7.59 (dd, J=2.0, 8.0Hz, 1H), 7.28 (d, J=8.0Hz, 1H), 3.25 (s, 3H), 1.47 (s, 9H).
Reference: [1] Patent: US2012/142708, 2012, A1, . Location in patent: Page/Page column 23
[2] Patent: WO2005/42537, 2005, A1, . Location in patent: Page/Page column 46; 47
[3] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 16, p. 3700 - 3705
[4] European Journal of Organic Chemistry, 2001, # 2, p. 311 - 322
[5] Journal of Medicinal Chemistry, 2008, vol. 51, # 1, p. 4 - 16
[6] Angewandte Chemie - International Edition, 2017, vol. 56, # 47, p. 14918 - 14922[7] Angew. Chem., 2017, vol. 129, # 47, p. 15114 - 15118,5
  • 2
  • [ 330807-44-8 ]
  • [ 231958-04-6 ]
YieldReaction ConditionsOperation in experiment
74.7%
Stage #1: With water; sodium hydroxide In 1,4-dioxane at 20℃; for 12 h;
Stage #2: at 0℃;
To a stirred solution of 3-tert-butoxycarbonylamino-4-methyl-benzoic acid methyl ester (0.35 g, 1.32 mmol) in 1,4-dioxane (10 mL) was added an aqueous solution of sodium hydroxide (1N, 2.5 mL) and reaction mixture was stirred at room temperature for 12 hours (monitored by silica TLC; ethyl acetate-hexanes, 1:1).
Water was distilled off under reduced pressure; obtained crude sodium salt was acidified with acetic acid solution at 0° C. and was extracted with (2*20 mL).
Collected organic parts were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give 3-tert-butoxycarbonylamino-4-methyl-benzoic acid as off white solid, which was taken to the next step without further purification. (Yield 1.20 g, 74.7percent).
Reference: [1] Patent: US2012/184548, 2012, A1, . Location in patent: Page/Page column 41
  • 3
  • [ 18595-18-1 ]
  • [ 231958-04-6 ]
Reference: [1] Patent: US2012/184548, 2012, A1,
  • 4
  • [ 24424-99-5 ]
  • [ 231958-04-6 ]
Reference: [1] Patent: US2012/184548, 2012, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 231958-04-6 ]

Aryls

Chemical Structure| 180976-94-7

[ 180976-94-7 ]

4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid

Similarity: 0.99

Chemical Structure| 669713-59-1

[ 669713-59-1 ]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.93

Chemical Structure| 306937-20-2

[ 306937-20-2 ]

5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid

Similarity: 0.85

Chemical Structure| 144072-30-0

[ 144072-30-0 ]

(4-Formyl-phenyl)-carbamicacidtert-butylester

Similarity: 0.84

Amides

Chemical Structure| 180976-94-7

[ 180976-94-7 ]

4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid

Similarity: 0.99

Chemical Structure| 669713-59-1

[ 669713-59-1 ]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.93

Chemical Structure| 354587-63-6

[ 354587-63-6 ]

1-tert-Butyl 6-methyl 1H-indole-1,6-dicarboxylate

Similarity: 0.88

Chemical Structure| 306937-20-2

[ 306937-20-2 ]

5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid

Similarity: 0.85

Amines

Chemical Structure| 180976-94-7

[ 180976-94-7 ]

4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid

Similarity: 0.99

Chemical Structure| 669713-59-1

[ 669713-59-1 ]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.93

Chemical Structure| 306937-20-2

[ 306937-20-2 ]

5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid

Similarity: 0.85

Chemical Structure| 144072-30-0

[ 144072-30-0 ]

(4-Formyl-phenyl)-carbamicacidtert-butylester

Similarity: 0.84

Carboxylic Acids

Chemical Structure| 180976-94-7

[ 180976-94-7 ]

4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid

Similarity: 0.99

Chemical Structure| 669713-59-1

[ 669713-59-1 ]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.93

Chemical Structure| 306937-20-2

[ 306937-20-2 ]

5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid

Similarity: 0.85

Chemical Structure| 33233-67-9

[ 33233-67-9 ]

4-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.84